These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 24581956)

  • 1. Impact of flexible insulin therapy on blood glucose variability, oxidative stress and inflammation in type 1 diabetic patients: the VARIAFIT study.
    Benhamou PY; Somers F; Lablanche S; Debaty I; Borel AL; Nasse L; Stanke-Labesque F; Faure P; Boizel R; Halimi S
    Diabetes Metab; 2014 Sep; 40(4):278-83. PubMed ID: 24581956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine.
    Bruttomesso D; Crazzolara D; Maran A; Costa S; Dal Pos M; Girelli A; Lepore G; Aragona M; Iori E; Valentini U; Del Prato S; Tiengo A; Buhr A; Trevisan R; Baritussio A
    Diabet Med; 2008 Mar; 25(3):326-32. PubMed ID: 18307459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized clinical trial comparing the effect of basal insulin and inhaled mealtime insulin on glucose variability and oxidative stress.
    Siegelaar SE; Kulik W; van Lenthe H; Mukherjee R; Hoekstra JB; Devries JH
    Diabetes Obes Metab; 2009 Jul; 11(7):709-14. PubMed ID: 19320663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Glycemic variability and oxidative stress in children, with type 1 diabetes attending a summer camp].
    Colomo N; Tapia MJ; Vallejo MR; García-Torres F; Rubio-Martín E; Caballero FF; Jiménez JM; Pelaez MJ; Gómez AM; Sánchez I; López-Siguero JP; Soriguer F; Ruiz de Adana MS
    An Pediatr (Barc); 2014 Sep; 81(3):174-80. PubMed ID: 24290964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular function and glucose variability improve transiently following initiation of continuous subcutaneous insulin infusion in children with type 1 diabetes.
    Harrington J; Peña AS; Wilson L; Gent R; Dowling K; Baghurst P; Couper J
    Pediatr Diabetes; 2013 Nov; 14(7):504-11. PubMed ID: 23659762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycaemic variability in paediatric patients with type 1 diabetes on continuous subcutaneous insulin infusion (CSII) or multiple daily injections (MDI): a cross-sectional cohort study.
    Schreiver C; Jacoby U; Watzer B; Thomas A; Haffner D; Fischer DC
    Clin Endocrinol (Oxf); 2013 Nov; 79(5):641-7. PubMed ID: 23134485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between blood glucose fluctuations and activation of oxidative stress in type 1 diabetic children during the acute metabolic disturbance period.
    Wu D; Gong CX; Meng X; Yang QL
    Chin Med J (Engl); 2013 Nov; 126(21):4019-22. PubMed ID: 24229667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a new measure of blood glucose variability in diabetes.
    Kovatchev BP; Otto E; Cox D; Gonder-Frederick L; Clarke W
    Diabetes Care; 2006 Nov; 29(11):2433-8. PubMed ID: 17065680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationships between glucose variability and conventional measures of glycemic control in continuously monitored patients with type 2 diabetes.
    Kohnert KD; Vogt L; Augstein P; Heinke P; Zander E; Peterson K; Freyse EJ; Salzsieder E
    Horm Metab Res; 2009 Feb; 41(2):137-41. PubMed ID: 19214924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Difference in urinary 11-dehydro TXB2 and LTE4 excretion in patients with rheumatoid arthritis.
    Nakamura H; Hishinuma T; Suzuki N; Chiba S; Tsukamoto H; Takabatake M; Sawai T; Mitomo T; Inoue H; Matsumoto F; Mizugaki M
    Prostaglandins Leukot Essent Fatty Acids; 2001; 65(5-6):301-6. PubMed ID: 11993724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of oxidative stress and inflammation by glycaemic control: evidence for reversible activation of the 5-lipoxygenase pathway in type 1, but not in type 2 diabetes.
    Boizel R; Bruttmann G; Benhamou PY; Halimi S; Stanke-Labesque F
    Diabetologia; 2010 Sep; 53(9):2068-70. PubMed ID: 20535444
    [No Abstract]   [Full Text] [Related]  

  • 12. Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration.
    Davì G; Chiarelli F; Santilli F; Pomilio M; Vigneri S; Falco A; Basili S; Ciabattoni G; Patrono C
    Circulation; 2003 Jul; 107(25):3199-203. PubMed ID: 12810609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose fluctuations and activation of oxidative stress in patients with type 1 diabetes.
    Wentholt IM; Kulik W; Michels RP; Hoekstra JB; DeVries JH
    Diabetologia; 2008 Jan; 51(1):183-90. PubMed ID: 17994218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary excretion of leukotriene E4 and 11-dehydro-thromboxane B2 in response to bronchial provocations with allergen, aspirin, leukotriene D4, and histamine in asthmatics.
    Kumlin M; Dahlén B; Björck T; Zetterström O; Granström E; Dahlén SE
    Am Rev Respir Dis; 1992 Jul; 146(1):96-103. PubMed ID: 1320824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus.
    Santilli F; Davì G; Consoli A; Cipollone F; Mezzetti A; Falco A; Taraborelli T; Devangelio E; Ciabattoni G; Basili S; Patrono C
    J Am Coll Cardiol; 2006 Jan; 47(2):391-7. PubMed ID: 16412866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of human insulin and insulin analogues on hypoglycaemia and metabolic variability in type 1 diabetes using standardized measurements (HYPO score and Lability Index).
    Pérez-Maraver M; Caballero-Corchuelo J; Boltana A; Insa R; Soler J; Montanya E
    Acta Diabetol; 2013 Aug; 50(4):529-35. PubMed ID: 21874353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effects of real-time continuous glucose monitoring on oxidative stress and mortality in critically ill patients].
    Qian WQ; Jin ZC; Cai Y; Kong XR; Ji MS
    Zhonghua Nei Ke Za Zhi; 2013 Jan; 52(1):30-3. PubMed ID: 23710812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Benefits of subcutaneous continuous insulin infusion in type 1 diabetic patients with high glycemic variability].
    Prieto-Tenreiro A; Villar-Taibo R; Pazos-Couselo M; González-Rodríguez M; Casanueva F; García-López JM
    Endocrinol Nutr; 2012 Apr; 59(4):246-53. PubMed ID: 22440045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved glycaemic variability and basal insulin dose reduction during a running competition in recreationally active adults with type 1 diabetes-A single-centre, prospective, controlled observational study.
    Moser O; Mueller A; Eckstein ML; Ziko H; Aberer F; Treiber G; Unteregger C; Kojzar H; Mader JK; Sourij C; Pferschy P; Obermayer A; Tripolt N; Sourij H
    PLoS One; 2020; 15(9):e0239091. PubMed ID: 32915897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.